SILREAL GmbH is a strategic advisory firm operating at the intersection of healthcare policy, regulation, and cross-border market access.

We support pharma, biotech, medtech, and healthcare investors in navigating high-stakes regulatory and political environments across Europe, China, and the United States.

Our core work focuses on:
	•	Policy-driven market access (EU, China, US)
	•	Government affairs & regulatory intelligence
	•	Cross-border partnerships and licensing
	•	Health system integration & procurement strategy

SILREAL is trusted by global life sciences leaders, including AstraZeneca, Bayer, Roche, Sartorius, and public institutions such as the German Federal Ministry of Health and EU-level bodies.

What differentiates us:
	•	We translate policy signals into commercial decisions
	•	We operate as a risk filter for C-level and Boards
	•	We design mandate-led EU–China partnerships with real execution power

SILREAL is not a market research firm.
We work on retainer-based strategic mandates where regulatory, political, and industrial policy directly impact revenue, investment, and long-term positioning.

Typical clients: CEOs, CSOs, Heads of Global Policy, Market Access, Corporate Strategy, BD, and Healthcare Investors.

Focus sectors: Pharma • Biotech • Medtech • Digital Health • Health AI • Healthcare Infrastructure

🌍 Europe | China | United States
📍 Headquarters: Berlin
🔗 www.silreal.com

SILREAL

Org chart

Teams

Offices